CN116421619A - Application of non-cytotoxic potential water in prevention and treatment of new coronavirus infection - Google Patents
Application of non-cytotoxic potential water in prevention and treatment of new coronavirus infection Download PDFInfo
- Publication number
- CN116421619A CN116421619A CN202211729343.2A CN202211729343A CN116421619A CN 116421619 A CN116421619 A CN 116421619A CN 202211729343 A CN202211729343 A CN 202211729343A CN 116421619 A CN116421619 A CN 116421619A
- Authority
- CN
- China
- Prior art keywords
- water
- treatment
- potential water
- acidic
- prevention
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 90
- 208000001528 Coronaviridae Infections Diseases 0.000 title claims abstract description 13
- 231100000065 noncytotoxic Toxicity 0.000 title claims abstract description 11
- 230000002020 noncytotoxic effect Effects 0.000 title claims abstract description 11
- 230000002265 prevention Effects 0.000 title claims description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 22
- 210000001508 eye Anatomy 0.000 claims abstract description 13
- 230000000694 effects Effects 0.000 claims abstract description 11
- 239000011780 sodium chloride Substances 0.000 claims abstract description 11
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 8
- 238000000889 atomisation Methods 0.000 claims abstract description 3
- 230000002378 acidificating effect Effects 0.000 claims description 47
- 230000003647 oxidation Effects 0.000 claims description 27
- 238000007254 oxidation reaction Methods 0.000 claims description 27
- 230000001590 oxidative effect Effects 0.000 claims description 24
- 210000003928 nasal cavity Anatomy 0.000 claims description 14
- 241000711573 Coronaviridae Species 0.000 claims description 7
- 208000015181 infectious disease Diseases 0.000 claims description 7
- 239000000645 desinfectant Substances 0.000 claims description 6
- 239000008213 purified water Substances 0.000 claims description 6
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 5
- 239000000460 chlorine Substances 0.000 claims description 5
- 229910052801 chlorine Inorganic materials 0.000 claims description 5
- 238000005868 electrolysis reaction Methods 0.000 claims description 5
- 238000001223 reverse osmosis Methods 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- 230000002262 irrigation Effects 0.000 claims description 2
- 238000003973 irrigation Methods 0.000 claims description 2
- 231100001083 no cytotoxicity Toxicity 0.000 abstract description 19
- 210000000621 bronchi Anatomy 0.000 abstract description 15
- 210000002345 respiratory system Anatomy 0.000 abstract description 13
- 210000004400 mucous membrane Anatomy 0.000 abstract description 8
- 239000003381 stabilizer Substances 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 5
- 210000001331 nose Anatomy 0.000 abstract description 2
- 238000004904 shortening Methods 0.000 abstract description 2
- 230000000638 stimulation Effects 0.000 abstract description 2
- 238000000034 method Methods 0.000 description 14
- 210000000214 mouth Anatomy 0.000 description 12
- 206010036790 Productive cough Diseases 0.000 description 11
- 208000024794 sputum Diseases 0.000 description 11
- 210000003802 sputum Anatomy 0.000 description 11
- 239000003242 anti bacterial agent Substances 0.000 description 5
- 229940088710 antibiotic agent Drugs 0.000 description 5
- 208000023504 respiratory system disease Diseases 0.000 description 5
- 206010035664 Pneumonia Diseases 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 208000026425 severe pneumonia Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 210000003456 pulmonary alveoli Anatomy 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 231100000699 Bacterial toxin Toxicity 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000000688 bacterial toxin Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
The invention relates to application of non-cytotoxic potential water in preventing and treating new coronavirus infection. The sterile potential water provided by the invention is easy to obtain by electrolyzing sodium chloride through direct current, has no chemical stabilizer, is bottled sterile stable, has no cytotoxicity, can be quickly converted into common water after being used, has no residue, is convenient to use, is widely applicable to people, can be used by infants and the elderly, has no use amount limitation, has no stimulation to skin and mucous membrane, can be used for entering fragile parts of human bodies such as nose, eyes and respiratory tract, and has wide disinfection application range; the auxiliary treatment effect can be carried out on bronchi and alveoli after atomization treatment, thereby shortening the period of illness, improving the cure rate of the illness and having good treatment effect.
Description
Technical Field
The invention relates to the technical field of disinfection products, in particular to application of non-cytotoxic potential water in preventing and treating new coronavirus infection.
Background
The mucous membrane of the human body such as the oral cavity, the nasal cavity and the like is a very weak part, can not be disinfected by alcohol, and can not use chemical agents and medicines in large doses for a long time, so that the diseases infected by the mucous membrane such as the nasal cavity, the oral cavity, the eyes and the like can not be well prevented and blocked in advance, and serious diseases can be caused. Therefore, there is a need for a disinfectant which is harmless to the human body and can be used for disinfecting the oral cavity and the nasal cavity to prevent and treat infections of respiratory diseases such as coronaviruses.
Disclosure of Invention
In view of the problems existing in the prior art, the invention discloses application of non-cytotoxic potential water in preventing and treating new coronavirus infection, which is characterized in that sodium chloride with the mass ratio of 0.05% is added into purified water obtained by secondary reverse osmosis, a sodium chloride solution is prepared, electrolytic water at the anode end is obtained through direct current electrolysis, the acidic potential water is sterile bottled and packaged steady-state potential water, the non-cytotoxicity potential water is non-acidic, the PH of the acidic potential water is 2.0-3.0, the oxidation potential is more than or equal to +1100mv, the available chlorine content is 25-80ppm, the obtained acidic potential water is used as a disinfectant, and mouth washing can be carried out, so that oral cavity is disinfected, throat, nasal cavity and eyes can be sprayed in a spray mode, throat mucous membrane can be disinfected, nasal cavity and eyes can be washed and disinfected, and the method can be used for preventing and treating infection of respiratory diseases such as new coronavirus.
When the invention is used, the acidic electrolyzed oxidizing water is atomized by the atomizer, and after being sprayed into the oral cavity, tiny atomized particles can enter the respiratory tract to play a role in sterilization and disinfection in the respiratory tract; can also be used for nasal cavity irrigation and bronchoalveolar lavage of patients with pneumonia.
The acidic oxidation potential water bronchoalveolar lavage treatment can discharge the sputum which is difficult to expectorate and exists in the bronchus of a patient, and the sputum plug and inflammatory secretion in the bronchus of the patient are cleared through multiple lavage and suction, so that the method has an extremely important influence on the smooth progress of the sputum discharge. The bronchoalveolar lavage with the acidic electrolyzed oxidizing water can remove sputum at the bronchus and alveolus parts of the lung and increase the concentration of related medicines, which has important significance for ensuring the sputum removing effect. The stimulation degree of the alveolar mucosa can be improved in the lavage process of the bronchoalveoli, so that the cough reflex effect of a patient can be enhanced, and conditions are created for further discharge of sputum of the patient. The acidic electrolyzed oxidizing water is in a sterile stable state and has no cytotoxicity, so that the acidic electrolyzed oxidizing water is harmless to human bodies after lavage.
In the treatment process of severe pneumonia patients, the bronchoalveolar lavage with acidic electrolyzed oxidizing water can effectively improve the condition of patient dyspnea. Compared with other treatment modes, the method has a plurality of advantages, and the whole process can be carried out in a visible state when the technology is applied to remove bronchus or alveolus sputum of a patient, so that the method has great significance for improving sputum suction effectiveness. Furthermore, the potential for acidic oxidative potential water bronchoalveolar lavage treatment is relatively less likely to contaminate the lavage fluid or bronchial secretions pumped during the treatment, which can ensure a positive rate of relevant bacterial cultures, with great effect on the selection of appropriate antibiotics. The adoption of targeted antibiotics can greatly reduce the drug resistance of bacteria, which is extremely important for ensuring the treatment effectiveness of patients. When the alveolus lavage is carried out on a patient, relevant lavage liquid needs to be applied, and the application of the lavage liquid can dilute the viscosity degree of the bronchial secretions of the patient, so that the bacterial toxin level of the lesion part of the patient is reduced, and the absorption of toxin by tissues can be effectively controlled. The medicine concentration of the focus part of the patient can be improved in the alveolar lavage process of the patient, which has important significance for the exertion of the antibiotic effect.
The invention has the beneficial effects that: the potential water provided by the invention has no chemical stabilizer, is in a bottled sterile stable state, has no cytotoxicity, can be quickly converted into common water after being used, has no residue, is convenient to use, is widely applicable to people, can be used by infants and the elderly, has no usage amount limitation, has no irritation to skin and mucous membrane, can enter fragile parts of human bodies such as nose, eyes and respiratory tract, and has wide disinfection application range; the auxiliary treatment effect can be carried out on bronchi and alveoli after atomization treatment, thereby shortening the period of illness, improving the cure rate of the illness and having good treatment effect.
Detailed Description
Example 1
The invention relates to application of non-cytotoxicity potential water in preventing and treating new coronavirus infection, which is characterized in that sodium chloride with the mass ratio of 0.05% is added into purified water obtained by secondary reverse osmosis, sodium chloride solution is obtained by blending, the electrolyzed water at the anode end is acidic oxidation potential water obtained by direct current electrolysis, the acidic oxidation potential water is steady-state potential water packaged in a sterile bottle, the non-cytotoxicity potential water is non-cytotoxicity, the PH of the acidic oxidation potential water is 2.0, the oxidation potential is more than or equal to +1100mv, the effective chlorine content is 25ppm, and the obtained acidic oxidation potential water is used as disinfectant, has no chemical stabilizer and no cytotoxicity, can be quickly converted into common water after being used, and has no residue.
The sterile acidic electrolyzed oxidizing water can be used for gargling, so that the oral cavity can be disinfected, and the sterile acidic electrolyzed oxidizing water can be sprayed into throat, nasal cavity and eyes in a spray mode, disinfects throat mucous membranes, washes and disinfects the nasal cavity and eyes, and can be used for preventing and treating infection of respiratory diseases such as new coronaviruses. The acidic oxidation potential water is atomized by the atomizer, and tiny atomized particles can enter the respiratory tract after being sprayed into the oral cavity, so that the sterilization and disinfection effects are achieved in the respiratory tract. The method can also be used for lavaging bronchi alveoli of a patient suffering from pneumonia, and lavaging bronchi alveoli by acidic oxidation potential water in the treatment process of the patient suffering from severe pneumonia can effectively improve the unobstructed condition of the respiratory tract of the patient, ensure the high efficiency of sputum aspiration of bronchi or alveoli of the patient, and is very important for improving the treatment effectiveness of the patient. In addition, the application of the electrolyzed oxidizing water to lavage the bronchioloalveolar can also provide guiding basis for the use of related antibiotics, thereby creating conditions for the exertion of the antibiotic effect to the greatest extent. The acidic electrolyzed oxidizing water is in a sterile stable state and has no cytotoxicity, so that the acidic electrolyzed oxidizing water is harmless to human bodies after lavage.
Example 2
The invention relates to application of non-cytotoxicity potential water in preventing and treating new coronavirus infection, which is characterized in that sodium chloride with the mass ratio of 0.05% is added into purified water obtained by secondary reverse osmosis, sodium chloride solution is obtained by blending, the electrolyzed water at the anode end is acidic oxidation potential water obtained by direct current electrolysis, the acidic oxidation potential water is steady-state potential water packaged in a sterile bottle, the non-cytotoxicity potential water is non-cytotoxicity, the PH of the acidic oxidation potential water is 3.0, the oxidation potential is more than or equal to +1100mv, the effective chlorine content is 80ppm, and the obtained acidic oxidation potential water is used as disinfectant, has no chemical stabilizer and no cytotoxicity, can be quickly converted into common water after being used, and has no residue.
The sterile acidic electrolyzed oxidizing water can be used for gargling, so that the oral cavity can be disinfected, and the sterile acidic electrolyzed oxidizing water can be sprayed into throat, nasal cavity and eyes in a spray mode, disinfects throat mucous membranes, washes and disinfects the nasal cavity and eyes, and can be used for preventing and treating infection of respiratory diseases such as new coronaviruses. The acidic oxidation potential water is atomized by the atomizer, and tiny atomized particles can enter the respiratory tract after being sprayed into the oral cavity, so that the sterilization and disinfection effects are achieved in the respiratory tract. The method can also be used for lavaging bronchi alveoli of a patient suffering from pneumonia, and lavaging bronchi alveoli by acidic oxidation potential water in the treatment process of the patient suffering from severe pneumonia can effectively improve the unobstructed condition of the respiratory tract of the patient, ensure the high efficiency of sputum aspiration of bronchi or alveoli of the patient, and is very important for improving the treatment effectiveness of the patient. In addition, the application of the electrolyzed oxidizing water to lavage the bronchioloalveolar can also provide guiding basis for the use of related antibiotics, thereby creating conditions for the exertion of the antibiotic effect to the greatest extent. The acidic electrolyzed oxidizing water is in a sterile stable state and has no cytotoxicity, so that the acidic electrolyzed oxidizing water is harmless to human bodies after lavage.
Example 3
The invention relates to application of non-cytotoxicity potential water in preventing and treating new coronavirus infection, which is characterized in that sodium chloride with the mass ratio of 0.05% is added into purified water obtained by secondary reverse osmosis, sodium chloride solution is obtained by blending, the electrolyzed water at the anode end is acidic oxidation potential water obtained by direct current electrolysis, the acidic oxidation potential water is steady-state potential water packaged in a sterile bottle, the non-cytotoxicity potential water is non-cytotoxicity, the PH of the acidic oxidation potential water is 2.5, the oxidation potential is more than or equal to +1100mv, the effective chlorine content is 50ppm, and the obtained acidic oxidation potential water is used as disinfectant, has no chemical stabilizer and no cytotoxicity, can be quickly converted into common water after being used, and has no residue.
The sterile acidic electrolyzed oxidizing water can be used for gargling, so that the oral cavity can be disinfected, and the sterile acidic electrolyzed oxidizing water can be sprayed into throat, nasal cavity and eyes in a spray mode, disinfects throat mucous membranes, washes and disinfects the nasal cavity and eyes, and can be used for preventing and treating infection of respiratory diseases such as new coronaviruses. The acidic oxidation potential water is atomized by the atomizer, and tiny atomized particles can enter the respiratory tract after being sprayed into the oral cavity, so that the sterilization and disinfection effects are achieved in the respiratory tract. The method can also be used for lavaging bronchi alveoli of a patient suffering from pneumonia, and lavaging bronchi alveoli by acidic oxidation potential water in the treatment process of the patient suffering from severe pneumonia can effectively improve the unobstructed condition of the respiratory tract of the patient, ensure the high efficiency of sputum aspiration of bronchi or alveoli of the patient, and is very important for improving the treatment effectiveness of the patient. In addition, the application of the electrolyzed oxidizing water to lavage the bronchioloalveolar can also provide guiding basis for the use of related antibiotics, thereby creating conditions for the exertion of the antibiotic effect to the greatest extent. The acidic electrolyzed oxidizing water is in a sterile stable state and has no cytotoxicity, so that the acidic electrolyzed oxidizing water is harmless to human bodies after lavage.
The portions not described in detail herein are prior art.
Although the specific embodiments of the present invention have been described in detail, the present invention is not limited to the above embodiments, and various changes and modifications without inventive labor may be made within the scope of the present invention without departing from the spirit of the present invention, which is within the scope of the present invention.
Claims (6)
1. The application of the non-cytotoxic electrolyzed water in preventing and treating the infection of the novel coronavirus is characterized in that purified water is selected, sodium chloride with the mass ratio of 0.05% is added, a sodium chloride solution is prepared, the electrolyzed water at the anode end is obtained through direct current electrolysis as the electrolyzed water with the acidic oxidation potential, and the obtained electrolyzed water with the acidic oxidation potential is used as a disinfectant for preventing and treating the infection of the novel coronavirus.
2. Use of a non-cytotoxic potential water according to claim 1 for the prevention and treatment of a new coronavirus infection, wherein: the purified water is obtained by the secondary reverse osmosis.
3. Use of a non-cytotoxic potential water according to claim 1 for the prevention and treatment of a new coronavirus infection, wherein: the PH of the acidic electrolyzed oxidizing water is 2.0-3.0, the oxidation potential is more than or equal to +1100mv, and the effective chlorine content is 25-80ppm.
4. Use of a non-cytotoxic potential water according to claim 1 for the prevention and treatment of a new coronavirus infection, wherein: the acidic electrolyzed oxidizing water is used in any one of spray, atomization or irrigation, acts on throat, nasal cavity and eyes, and disinfects the nasal cavity and eyes.
5. Use of a non-cytotoxic potential water according to claim 1 for the prevention and treatment of a new coronavirus infection, wherein: the acidic electrolyzed oxidizing water is used for rinsing the mouth to achieve the disinfection effect.
6. Use of a non-cytotoxic potential water according to claim 1 for the prevention and treatment of a new coronavirus infection, wherein: the acidic oxidation potential water is steady-state potential water packaged in a sterile bottle.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211729343.2A CN116421619A (en) | 2022-12-30 | 2022-12-30 | Application of non-cytotoxic potential water in prevention and treatment of new coronavirus infection |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211729343.2A CN116421619A (en) | 2022-12-30 | 2022-12-30 | Application of non-cytotoxic potential water in prevention and treatment of new coronavirus infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116421619A true CN116421619A (en) | 2023-07-14 |
Family
ID=87080344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211729343.2A Withdrawn CN116421619A (en) | 2022-12-30 | 2022-12-30 | Application of non-cytotoxic potential water in prevention and treatment of new coronavirus infection |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116421619A (en) |
-
2022
- 2022-12-30 CN CN202211729343.2A patent/CN116421619A/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2680483C (en) | Antimicrobial solutions containing dichlorine monoxide and methods of making and using the same | |
| JP6956143B2 (en) | Antimicrobial composition and how to use it | |
| JP2007517064A5 (en) | ||
| JP2006505516A (en) | Physiologically balanced ionized acidic solution and method of use in wound healing | |
| CN110799179A (en) | Solid composition comprising iodine reagent and sodium chloride with improved water solubility and antiviral and antibacterial composition for eye, oral cavity, nasal cavity or inhalation comprising aqueous solution thereof | |
| CN104958830A (en) | Subacid electrolyzed oxidizing water gynecological anti-infection treatment facility | |
| CN104856867A (en) | Subacidity oxidation electric potential water treatment apparatus | |
| CN108743776A (en) | A kind of flushing powder for nasal disease prevention | |
| CN107899006A (en) | Pharmaceutical composition of nasal irrigation and preparation method thereof | |
| US20190125790A1 (en) | Use of hypochlorous acid as a topical antimicrobial | |
| CN116421619A (en) | Application of non-cytotoxic potential water in prevention and treatment of new coronavirus infection | |
| US20060034947A1 (en) | Erythritol compositions for nasopharynx cleansing | |
| CN112870110A (en) | Halitosis-resisting toothpaste | |
| CN104523513A (en) | Tooth cleaning fluid | |
| CN104524559A (en) | Lysostaphic complex enzyme oral cavity disinfectant and preparation method thereof | |
| WO2010004653A1 (en) | Eradicating agent and eradication method for helicobacter pylori | |
| RU2742505C1 (en) | Aerosol for invasive mechanical ventilation in covid-19 | |
| KR20170141870A (en) | Mouth and nose cleaning liquid comprising oxygen | |
| CA2852591C (en) | Vitamin d3 compositions and uses thereof for the treatment of nasal passages | |
| RU2635992C1 (en) | Aerated mouthwash | |
| RU2736046C1 (en) | Method of treating chronic pharyngitis | |
| US20210177892A1 (en) | Prevention and treatment of infectious disease using low concentration hypochlorous acid solutions | |
| Pilania et al. | Ozone therapy–a milestone in dentistry; a review | |
| RU2329795C2 (en) | Method of cows' gynaecological disease treatment including application of gas-cut water medicinal solutions | |
| CN115177540A (en) | Preparation method of oral comprehensive care solution |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20230714 |